Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Levothyroxine Sodium
Therapeutic Area : Endocrinology
Study Phase : Approved
Recipient : Mannkind
Deal Size : Undisclosed
Deal Type : Agreement
MannKind and Vertice to Co-Promote Thyquidity™ (levothyroxine sodium) Oral Solution
Details : Vertice will make a specified quarterly payment to MannKind to defray the costs of the additional promotional activity and will pay MannKind royalties on gross profit resulting from all sales of Thyquidity.
Brand Name : Thyquidity
Molecule Type : Small molecule
Upfront Cash : Undisclosed
December 17, 2020
Lead Product(s) : Levothyroxine Sodium
Therapeutic Area : Endocrinology
Highest Development Status : Approved
Recipient : Mannkind
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?